Therapeutic vaccine research reagent

ESMO 2025: mRNA-based COVID vaccines generate improved responses to immunotherapy | UT MD Anderson

Published Time: 2025-10-19

Summary

This text appears to be the source code or raw content from a webpage for The University of Texas MD Anderson Cancer Center. The primary news article headline is "ESMO 2025: mRNA-based COVID vaccines generate improved responses to immunotherapy". However, the provided content consists predominantly of the website's extensive navigation structure and boilerplate elements, not the full article body.

Website Structure Content

The bulk of the provided text includes:

• Site header with logo, search, and appointment request links.
• Primary navigation menus for Patients & Family, Prevention & Screening, Donors & Volunteers, and other sections.
• Multiple nested lists detailing site pages such as Becoming Our Patient, Diagnosis & Treatment, Supporting a Loved One, Life After Cancer, Manage Your Risk, Family History, Cancer Screenings, Donate, Volunteer, and Corporate Alliances.
• Links for My Chart, Donate Today, Clinical Trials, Locations, Careers, Contact Us, and language options.
• Standard footer-like links and disclaimers are suggested by the structure but not fully detailed in the clip.

Note on Article Content

The actual news article content detailing the research findings on mRNA-based COVID vaccines and immunotherapy responses is not present in the provided text snippet. The snippet ends mid-sentence within a menu item ("Corpor...").

Available Information from Snippet